Top 5 Adventure Games on Android in Portugal: Q1 2023

In Q1 2023, the top 5 adventure games on the Android platform in Portugal showed diverse performance trends. Here’s an overview of the performance of Genshin Impact, Summoners War, Fate/Grand Order (English), The Seven Deadly Sins, and Mythic Heroes: Idle RPG.

Genshin Impact from COGNOSPHERE PTE. LTD. saw fluctuations in weekly revenue, peaking at around $8.7K in late December and early January, with a low of about $1.8K in mid-March. Weekly downloads remained fairly consistent, ranging from approximately 670 to 1.5K, while weekly active users saw a slight decline from 17.6K in late December to around 15.7K by the end of March.

Summoners War by Com2uS experienced variable weekly revenue, with a notable peak of about $3.9K in late February. Weekly downloads spiked in the same week, reaching approximately 1.1K, while weekly active users increased from around 4.4K in late December to a peak of 5.6K in late February, before dropping to about 3.9K by the end of March.

Fate/Grand Order (English) from Aniplex Inc. had a significant revenue peak of approximately $7.4K in early January. Weekly downloads were relatively low, oscillating between 49 and 177, while weekly active users remained stable, with minor fluctuations around the 580 to 600 mark throughout the quarter.

The Seven Deadly Sins by Netmarble showed a revenue peak of around $5.2K in early January. Weekly downloads were highest in the same period, reaching approximately 613, and weekly active users peaked at about 4K in early January before settling to around 2.7K by the end of March.

Mythic Heroes: Idle RPG from IGG.COM had a steady revenue with minor fluctuations, peaking at around $2.2K in early February. Weekly downloads varied between 25 and 53, while weekly active users showed a slight decline from approximately 1.5K in late December to around 1.4K by the end of March.

These insights come from Sensor Tower, offering detailed analytics on app performance. For more in-depth data, visit Sensor Tower.